172 related articles for article (PubMed ID: 34570619)
1. SUMO Modification of PAF1/PD2 Enables PML Interaction and Promotes Radiation Resistance in Pancreatic Ductal Adenocarcinoma.
Rauth S; Karmakar S; Shah A; Seshacharyulu P; Nimmakayala RK; Ganguly K; Bhatia R; Muniyan S; Kumar S; Dutta S; Lin C; Datta K; Batra SK; Ponnusamy MP
Mol Cell Biol; 2021 Nov; 41(12):e0013521. PubMed ID: 34570619
[TBL] [Abstract][Full Text] [Related]
2. PD2/Paf1 depletion in pancreatic acinar cells promotes acinar-to-ductal metaplasia.
Dey P; Rachagani S; Vaz AP; Ponnusamy MP; Batra SK
Oncotarget; 2014 Jun; 5(12):4480-91. PubMed ID: 24947474
[TBL] [Abstract][Full Text] [Related]
3. PAF1 cooperates with YAP1 in metaplastic ducts to promote pancreatic cancer.
Nimmakayala RK; Ogunleye AO; Parte S; Krishna Kumar N; Raut P; Varadharaj V; Perumal NK; Nallasamy P; Rauth S; Cox JL; Lele SM; Batra SK; Ponnusamy MP
Cell Death Dis; 2022 Oct; 13(10):839. PubMed ID: 36180487
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma.
Vaz AP; Deb S; Rachagani S; Dey P; Muniyan S; Lakshmanan I; Karmakar S; Smith L; Johansson S; Lele S; Ouellette M; Ponnusamy MP; Batra SK
Oncotarget; 2016 Jan; 7(3):3317-31. PubMed ID: 26689992
[TBL] [Abstract][Full Text] [Related]
5. The ND10 Component Promyelocytic Leukemia Protein Acts as an E3 Ligase for SUMOylation of the Major Immediate Early Protein IE1 of Human Cytomegalovirus.
Reuter N; Schilling EM; Scherer M; Müller R; Stamminger T
J Virol; 2017 May; 91(10):. PubMed ID: 28250117
[TBL] [Abstract][Full Text] [Related]
6. Role of SUMO in RNF4-mediated promyelocytic leukemia protein (PML) degradation: sumoylation of PML and phospho-switch control of its SUMO binding domain dissected in living cells.
Percherancier Y; Germain-Desprez D; Galisson F; Mascle XH; Dianoux L; Estephan P; Chelbi-Alix MK; Aubry M
J Biol Chem; 2009 Jun; 284(24):16595-16608. PubMed ID: 19380586
[TBL] [Abstract][Full Text] [Related]
7. PD2/PAF1 at the Crossroads of the Cancer Network.
Karmakar S; Dey P; Vaz AP; Bhaumik SR; Ponnusamy MP; Batra SK
Cancer Res; 2018 Jan; 78(2):313-319. PubMed ID: 29311159
[TBL] [Abstract][Full Text] [Related]
8. The SUMO pathway in pancreatic cancer: insights and inhibition.
Schneeweis C; Hassan Z; Schick M; Keller U; Schneider G
Br J Cancer; 2021 Feb; 124(3):531-538. PubMed ID: 33071285
[TBL] [Abstract][Full Text] [Related]
9. RNA Polymerase II-Associated Factor 1 Regulates Stem Cell Features of Pancreatic Cancer Cells, Independently of the PAF1 Complex, via Interactions With PHF5A and DDX3.
Karmakar S; Rauth S; Nallasamy P; Perumal N; Nimmakayala RK; Leon F; Gupta R; Barkeer S; Venkata RC; Raman V; Rachagani S; Ponnusamy MP; Batra SK
Gastroenterology; 2020 Nov; 159(5):1898-1915.e6. PubMed ID: 32781084
[TBL] [Abstract][Full Text] [Related]
10. PML hyposumoylation is responsible for the resistance of pancreatic cancer.
Swayden M; Alzeeb G; Masoud R; Berthois Y; Audebert S; Camoin L; Hannouche L; Vachon H; Gayet O; Bigonnet M; Roques J; Silvy F; Carrier A; Dusetti N; Iovanna JL; Soubeyran P
FASEB J; 2019 Nov; 33(11):12447-12463. PubMed ID: 31557059
[TBL] [Abstract][Full Text] [Related]
11. SUMOylation regulates the number and size of promyelocytic leukemia-nuclear bodies (PML-NBs) and arsenic perturbs SUMO dynamics on PML by insolubilizing PML in THP-1 cells.
Hirano S; Udagawa O
Arch Toxicol; 2022 Feb; 96(2):545-558. PubMed ID: 35001170
[TBL] [Abstract][Full Text] [Related]
12. Targeting cell surface GRP78 enhances pancreatic cancer radiosensitivity through YAP/TAZ protein signaling.
Gopal U; Mowery Y; Young K; Pizzo SV
J Biol Chem; 2019 Sep; 294(38):13939-13952. PubMed ID: 31358620
[TBL] [Abstract][Full Text] [Related]
13. Aberrant accumulation of Kras-dependent pervasive transcripts during tumor progression renders cancer cells dependent on PAF1 expression.
Liu X; Liu X; Du Y; Zou D; Tian C; Li Y; Lan X; David CJ; Sun Q; Chen M
Cell Rep; 2023 Aug; 42(8):112979. PubMed ID: 37572321
[TBL] [Abstract][Full Text] [Related]
14. Sumoylation of the Tumor Suppressor Promyelocytic Leukemia Protein Regulates Arsenic Trioxide-Induced Collagen Synthesis in Osteoblasts.
Xu WX; Liu SZ; Wu D; Qiao GF; Yan J
Cell Physiol Biochem; 2015; 37(4):1581-91. PubMed ID: 26517826
[TBL] [Abstract][Full Text] [Related]
15. Stability of Smyd1 in endothelial cells is controlled by PML-dependent SUMOylation upon cytokine stimulation.
Becker S; Steinemann G; Karle W; Roos K; Liem CH; Muralikumar S; Volkamer A; Munz B; Zakrzewicz A; Berkholz J
Biochem J; 2021 Jan; 478(1):217-234. PubMed ID: 33241844
[TBL] [Abstract][Full Text] [Related]
16. The oncogenic kinase Pim-1 is modulated by K-Ras signaling and mediates transformed growth and radioresistance in human pancreatic ductal adenocarcinoma cells.
Xu D; Allsop SA; Witherspoon SM; Snider JL; Yeh JJ; Fiordalisi JJ; White CD; Williams D; Cox AD; Baines AT
Carcinogenesis; 2011 Apr; 32(4):488-95. PubMed ID: 21262926
[TBL] [Abstract][Full Text] [Related]
17. Viral DNA Binding Protein SUMOylation Promotes PML Nuclear Body Localization Next to Viral Replication Centers.
Stubbe M; Mai J; Paulus C; Stubbe HC; Berscheminski J; Karimi M; Hofmann S; Weber E; Hadian K; Hay R; Groitl P; Nevels M; Dobner T; Schreiner S
mBio; 2020 Mar; 11(2):. PubMed ID: 32184235
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin-Proteasome System Regulation of an Evolutionarily Conserved RNA Polymerase II-Associated Factor 1 Involved in Pancreatic Oncogenesis.
Ferdoush J; Karmakar S; Barman P; Kaja A; Uprety B; Batra SK; Bhaumik SR
Biochemistry; 2017 Nov; 56(46):6083-6086. PubMed ID: 29023102
[TBL] [Abstract][Full Text] [Related]
19. SUMO pathway inhibition targets an aggressive pancreatic cancer subtype.
Biederstädt A; Hassan Z; Schneeweis C; Schick M; Schneider L; Muckenhuber A; Hong Y; Siegers G; Nilsson L; Wirth M; Dantes Z; Steiger K; Schunck K; Langston S; Lenhof HP; Coluccio A; Orben F; Slawska J; Scherger A; Saur D; Müller S; Rad R; Weichert W; Nilsson J; Reichert M; Schneider G; Keller U
Gut; 2020 Aug; 69(8):1472-1482. PubMed ID: 32001555
[TBL] [Abstract][Full Text] [Related]
20. SUMO modification of E1B-55K oncoprotein regulates isoform-specific binding to the tumour suppressor protein PML.
Wimmer P; Schreiner S; Everett RD; Sirma H; Groitl P; Dobner T
Oncogene; 2010 Oct; 29(40):5511-22. PubMed ID: 20639899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
